| Application no. and date | 14812658.4 (espacenet) (Federated) (European Patent Register), 20141203 | | Patent/reg. no. and date | DK/EP 3076969, 20210901 | | Publication date | 20161012 | | Priority no. and date | EP 13306679, 20131206 | | EP pub. no. and date |
EP 3076969 20161012 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | BT/GP/165358 | | Inventor | DI TOMASO, Emmanuelle, c/o Novartis Institutes for
BioMedical Research Inc.
250 Massachusetts Avenue
Cambridge, MA 02139, US,
TAVORATH, Ranjana, c/o Novartis Pharmaceuticals Corporation
One Health Plaza
East Hanover, NJ 07936, US,
GERMA, Marie-Caroline, c/o Novartis Pharma S.A.S.
Boite Postale 308
92506 Rueil-Malmaison Cedex, FR,
MASSACESI, Cristian, c/o Novartis Pharma S.A.S.
Boite Postale 308
92506 Rueil-Malmaison, FR,
FRITSCH, Christine, c/o Novartis Pharma AG
NIBR Klybeck Novartis
Institutes for Biomedical Research
Postfach
4002 Basel, CH,
SCHNELL, Christian Rene, c/o Novartis Pharma AG
NIBR Klybeck Novartis
Institutes for Biomedical Research
Postfach
4002 Basel, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/4439 (2006.01) , A61P 35/00 (2006.01) | | Title | Doseringsregime for en alfa-isoform-selektiv phosphatidylinositol-3-kinase-hæmmer | | Int. application no. | IB2014066558 | | Int. publication no. | WO2015083101 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
